169 related articles for article (PubMed ID: 34213649)
1. Multidisciplinary Management of Brain Metastases from Non-Small Cell Lung Cancer in the Era of Immunotherapy.
Sudmeier L; Tian S; Higgins KA
Curr Treat Options Oncol; 2021 Jul; 22(9):77. PubMed ID: 34213649
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiosurgery combined with anlotinib for limited brain metastases with perilesional edema in non-small cell lung cancer: Rvision-001 study protocol.
Wang Y; Wang X; Guan Y; Song Y; Zhuang H; Wang E
Thorac Cancer; 2020 May; 11(5):1361-1364. PubMed ID: 32163662
[TBL] [Abstract][Full Text] [Related]
3. Recent trends of characteristics and treatments in adults with newly diagnosed brain metastases.
Koide Y; Nagai N; Miyauchi R; Kitagawa T; Aoyama T; Shimizu H; Hashimoto S; Tachibana H; Kodaira T
Jpn J Clin Oncol; 2023 Jun; 53(7):572-580. PubMed ID: 37002189
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions.
Hartgerink D; van der Heijden B; De Ruysscher D; Postma A; Ackermans L; Hoeben A; Anten M; Lambin P; Terhaag K; Jochems A; Dekker A; Schoenmaekers J; Hendriks L; Zindler J
Front Oncol; 2018; 8():154. PubMed ID: 29868476
[TBL] [Abstract][Full Text] [Related]
5. Brain metastases from hepatocellular carcinoma: recent advances and future avenues.
Wang S; Wang A; Lin J; Xie Y; Wu L; Huang H; Bian J; Yang X; Wan X; Zhao H; Huang J
Oncotarget; 2017 Apr; 8(15):25814-25829. PubMed ID: 28445959
[TBL] [Abstract][Full Text] [Related]
6. Impact of Locoregional Therapies for Brain Lesions on Survival in Patients With Non-small Cell Lung Cancer With Multiple Extrathoracic Metastases.
Sakai K; Kuramoto J; Takahashi T; Kawano Y; Nishimura H; Kuwabara Y; Kojima A; Sasaki-Toda M; Ogawa-Kobayashi Y; Kikuchi S; Hirata Y; Mikami-Saito Y; Mikami S; Kyoyama H; Moriyama G; Koyama N; Uematsu K
Anticancer Res; 2023 Nov; 43(11):5107-5114. PubMed ID: 37909984
[TBL] [Abstract][Full Text] [Related]
7. Systemic Therapy for Melanoma Brain and Leptomeningeal Metastases.
Sherman WJ; Romiti E; Michaelides L; Moniz-Garcia D; Chaichana KL; Quiñones-Hinojosa A; Porter AB
Curr Treat Options Oncol; 2023 Dec; 24(12):1962-1977. PubMed ID: 38158477
[TBL] [Abstract][Full Text] [Related]
8. Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline.
Gondi V; Bauman G; Bradfield L; Burri SH; Cabrera AR; Cunningham DA; Eaton BR; Hattangadi-Gluth JA; Kim MM; Kotecha R; Kraemer L; Li J; Nagpal S; Rusthoven CG; Suh JH; Tomé WA; Wang TJC; Zimmer AS; Ziu M; Brown PD
Pract Radiat Oncol; 2022; 12(4):265-282. PubMed ID: 35534352
[TBL] [Abstract][Full Text] [Related]
9. Methods and results of locoregional treatment of brain metastases in patients with non-small cell lung cancer.
Patla A; Walasek T; Jakubowicz J; Blecharz P; Mituś JW; Mucha-Małecka A; Reinfuss M
Contemp Oncol (Pozn); 2016; 20(5):358-364. PubMed ID: 28373816
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic radionecrosis after postoperative but not preoperative stereotactic radiosurgery in a single patient: illustrative case.
Laurin BJ; Straza M; Noid G; Connelly JM; Mueller WM; Bovi J; Krucoff MO
J Neurosurg Case Lessons; 2023 Oct; 6(16):. PubMed ID: 37870754
[TBL] [Abstract][Full Text] [Related]
11. Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational Approaches.
Levis M; Gastino A; De Giorgi G; Mantovani C; Bironzo P; Mangherini L; Ricci AA; Ricardi U; Cassoni P; Bertero L
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760591
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy Alone.
Mills MN; Uno A; Li P; Liveringhouse C; Kim Y; Oliver DE; Perez BA; Creelan BC; Yu M; Forsyth PA; Pina Y; Ahmed KA
Clin Lung Cancer; 2024 Apr; ():. PubMed ID: 38719648
[TBL] [Abstract][Full Text] [Related]
13. Emergent radiotherapy for brain and leptomeningeal metastases: a narrative review.
Barbour AB; Zaki P; McGranahan TM; Venur V; Vellayappan B; Palmer J; Halasz LM; Yang JT; Blau M; Tseng YD; Chao ST; Suh JH; Foote M; Redmond KJ; Combs SE; Chang EL; Sahgal A; Lo SS
Ann Palliat Med; 2023 Nov; 12(6):1405-1419. PubMed ID: 37431225
[TBL] [Abstract][Full Text] [Related]
14. Navigating the Complexities of Brain Metastases Management.
Amouzegar A; Haig S; Kahn AM; Tawbi HA; Jones JA; Goldberg SB
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e433694. PubMed ID: 38781565
[TBL] [Abstract][Full Text] [Related]
15. Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.
Lukas RV; Lesniak MS; Salgia R
CNS Oncol; 2014 Jan; 3(1):61-75. PubMed ID: 25054901
[TBL] [Abstract][Full Text] [Related]
16. Emerging Immunotherapies in the Treatment of Brain Metastases.
Nieblas-Bedolla E; Nayyar N; Singh M; Sullivan RJ; Brastianos PK
Oncologist; 2021 Mar; 26(3):231-241. PubMed ID: 33103803
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary patient-centered management of brain metastases and future directions.
Palmer JD; Trifiletti DM; Gondi V; Chan M; Minniti G; Rusthoven CG; Schild SE; Mishra MV; Bovi J; Williams N; Lustberg M; Brown PD; Rao G; Roberge D
Neurooncol Adv; 2020; 2(1):vdaa034. PubMed ID: 32793882
[TBL] [Abstract][Full Text] [Related]
18. Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy.
Sereno M; Hernandez de Córdoba I; Gutiérrez-Gutiérrez G; Casado E
Front Immunol; 2023; 14():1297988. PubMed ID: 38283359
[TBL] [Abstract][Full Text] [Related]
19. Advances in the management of breast cancer brain metastases.
Sammons S; Van Swearingen AED; Chung C; Anders CK
Neurooncol Adv; 2021 Nov; 3(Suppl 5):v63-v74. PubMed ID: 34859234
[TBL] [Abstract][Full Text] [Related]
20. Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy.
Maria B; Antonella V; Michela R; Silvana G; Anita S; Anna Maria A; Chiara D; Paolo M
Ther Adv Med Oncol; 2016 Nov; 8(6):450-459. PubMed ID: 27800033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
